• Home
  • Study Details
Not currently enrolling

This study tests whether CT-155 improves negative symptoms associated with schizophrenia.

This study tests whether the investigational device CT-155 improves negative symptoms associated with schizophrenia.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is not currently enrolling.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Fred Jarskog
Psychiatry - General

Study Type

Clinical or Medical
Interventional

Study Topics

Behavior
Chronic Conditions
Mental and Emotional Health

IRB Number

23-0538

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research